Today's Daily Dose brings you news about Armata Pharma's receipt of a strategic investment from Innoviva; Cassava Sciences' near-term catalyst; encouraging data related to Hepion Pharma's NASH drug candidate CRV431 and merger of Conatus Pharma and privately-held Histogen.
from RTT - Biotech https://ift.tt/3aN0CTb
via IFTTT
No comments:
Post a Comment